Update from GOV.UK for: Medicines regulator approves up to 7.2mg dose of semaglutide (Wegovy) for patients with obesity only
Update from GOV.UK for: News and communications Medicines regulator approves up to 7.2mg dose of semaglutide (Wegovy) for patients with obesity only Page summary: The Medicines and Healthcare products Regulatory Agency (MHRA) approved a maximum dose of up…  | GOV.UK | | |
|
| Update from GOV.UK for: News and communications
Page summary:
The Medicines and Healthcare products Regulatory Agency (MHRA) approved a maximum dose of up to 7.2mg per week of semaglutide (Wegovy) on 6 January 2026. Change made:
First published. Time updated:
8:27am, 16 January 2026
Why am I getting this email?You asked GOV.UK to send you an email each time we add or update a page about: News and communications Unsubscribe Change your email preferences |
|
|
Kaffi's
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
No comments:
Post a Comment